M K Ferguson|L B Reeder|R Mick - JoVE Visualize

Showing results (131-140 of 234) with videos related to

Pageof 24

Sort By:

Annals of Surgery|May 1, 1986

Physiologic evaluation of esophageal function in patients with achalasia and diffuse esophageal spasmA G Little, D B Skinner, W H Chen, et al.

Human Gene Therapy|December 28, 1999

Combined therapy with chemotherapeutic agents and herpes simplex virus type 1 ICP34.5 mutant (HSV-1716) in human non-small cell lung cancerT Toyoizumi, R Mick, A E Abbas, et al.

Leukemia|December 1, 1994

Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515H M Golomb, R Dodge, R Mick, et al.

Gastroenterology|October 21, 2000

p16(INK4a) expression begins early in human colon neoplasia and correlates inversely with markers of cell proliferationC Y Dai, E E Furth, R Mick, et al.

Pharmacogenetics|February 1, 1996

Individualized dosing of amonafide based on a pharmacodynamic model incorporating acetylator phenotype and genderM J Ratain, R Mick, L Janisch, et al.

Cancer|October 1, 1994

Prognostic factors for survival in patients treated in phase I clinical trialsL Janisch, R Mick, R L Schilsky, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997

Pharmacokinetic and pharmacodynamic evaluation of the topoisomerase inhibitor irinotecan in cancer patientsE Gupta, R Mick, J Ramirez, et al.

Journal of the National Cancer Institute|June 3, 1992

Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancerE E Vokes, R R Weichselbaum, R Mick, et al.

Clinical Pharmacology and Therapeutics|November 1, 1991

Paradoxical relationship between acetylator phenotype and amonafide toxicityM J Ratain, R Mick, F Berezin, et al.

Leukemia|January 1, 1996

Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndromeS Rosati, R Mick, F Xu, et al.

Pageof 24

Showing results (131-140 of 234) with videos related to

Sort By:

Pageof 24

Annals of Surgery|May 1, 1986

Physiologic evaluation of esophageal function in patients with achalasia and diffuse esophageal spasmA G Little, D B Skinner, W H Chen, et al.

Human Gene Therapy|December 28, 1999

Combined therapy with chemotherapeutic agents and herpes simplex virus type 1 ICP34.5 mutant (HSV-1716) in human non-small cell lung cancerT Toyoizumi, R Mick, A E Abbas, et al.

Leukemia|December 1, 1994

Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515H M Golomb, R Dodge, R Mick, et al.

Gastroenterology|October 21, 2000

p16(INK4a) expression begins early in human colon neoplasia and correlates inversely with markers of cell proliferationC Y Dai, E E Furth, R Mick, et al.

Pharmacogenetics|February 1, 1996

Individualized dosing of amonafide based on a pharmacodynamic model incorporating acetylator phenotype and genderM J Ratain, R Mick, L Janisch, et al.

Cancer|October 1, 1994

Prognostic factors for survival in patients treated in phase I clinical trialsL Janisch, R Mick, R L Schilsky, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997

Pharmacokinetic and pharmacodynamic evaluation of the topoisomerase inhibitor irinotecan in cancer patientsE Gupta, R Mick, J Ramirez, et al.

Journal of the National Cancer Institute|June 3, 1992

Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancerE E Vokes, R R Weichselbaum, R Mick, et al.

Clinical Pharmacology and Therapeutics|November 1, 1991

Paradoxical relationship between acetylator phenotype and amonafide toxicityM J Ratain, R Mick, F Berezin, et al.

Leukemia|January 1, 1996

Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndromeS Rosati, R Mick, F Xu, et al.

Pageof 24